- Latuda® (lurasidone HCl) Label Updated With Expanded Dosing Range Providing Added Flexibility for the Treatment of Patients with Schizophrenia
MARLBOROUGH, Mass.–(BUSINESS WIRE)–Sunovion has announced that the US FDA has approved an expanded dose range for LATUDA (lurasidone HCl) in the treatment of adult patients with schizophrenia.
Digest powered by RSS Digest
